首页> 外文期刊>Autopsy & case reports. >Fas-ligand and caspase-3 positivity in three cases of histiocytic sarcoma: a different etiopathogenic pathway?
【24h】

Fas-ligand and caspase-3 positivity in three cases of histiocytic sarcoma: a different etiopathogenic pathway?

机译:Fas-配体和caspase-3阳性在三例组织细胞肉瘤中:不同的致病途径?

获取原文
           

摘要

Histiocytic sarcoma (HS) is a rare malignant neoplasia of hematopoietic origin and unknown etiology. We studied three patients with histiocytic sarcoma reviewing the morphological and immunohistochemical aspects. We evaluated in particular, if apoptosis may be unbalanced in this disease. All cases have morphological and immunohistochemical features consistent with the diagnosis of histiocytic sarcoma. The markers CD163, CD68, vimentin, lysozyme, and S-100 were positive in all cases. Similarly, the three samples were positive for Fas-ligand and Caspase-3. It is well-known that neoplasms may induce increased levels of Fas-ligand with the blockade of the apoptosis process. In the context of HS, the increased Fas-ligand expression represents a new area for research. Indeed, it is linked to proinflammatory stimulus and, maybe with the association of an infection.
机译:组织细胞肉瘤(HS)是造血起源和病因不明的罕见恶性肿瘤。我们研究了三例组织细胞肉瘤患者,并对其形态学和免疫组化方面进行了回顾。我们特别评估了这种疾病是否可能导致细胞凋亡失衡。所有病例均具有与组织细胞肉瘤的诊断一致的形态学和免疫组化特征。在所有情况下,标记CD163,CD68,波形蛋白,溶菌酶和S-100均为阳性。同样,三个样品的Fas-配体和Caspase-3均为阳性。众所周知,肿瘤可以诱导Fas-配体水平升高,并阻断细胞凋亡过程。在HS的背景下,Fas-配体表达的增加代表了一个新的研究领域。实际上,它与促炎刺激有关,也许与感染有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号